Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

A small 2020 study involving 29 people with peripheral neuropathy looked at the effectiveness of topical CBD oil for pain. The participants were divided into two groups: a treatment group that ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

“Access to the PSPP program will advance our understanding and development of ART26.12,” commented Saoirse O’Sullivan, PhD, Vice President Translational Science at Artelo Biosciences. “We are most ...

In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Professor Andrew Abell, Department of Chemistry and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), Institute for Photonics and ...

Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

Suneeta’s research centers on identifying novel molecular signatures and biomarkers to improve the efficacy of cancer ...